Inhibition of inflammatory hyperalgesia by activation of peripheral CB 2 cannabinoid receptors

Anesthesiology

Volumn 99, Issue 4, 2003, Pages 955-960

  Quartilho, Aline ^c   Mata, Heriberto P ^c   Ibrahim, Mohab M ^c   Vanderah, Todd W ^c   Porreca, Frank ^c   Makriyannis, Alexandros ^a   Malan Jr , T Philip ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CARRAGEENAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; HYPERALGESIA; INFLAMMATION; MALE; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; THERMAL STIMULATION;

ANALGESICS; ANIMALS; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HYPERALGESIA; INFLAMMATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0141655147     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200310000-00031     Document Type: Article

References (37)

1. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365:61-5
2. 2 receptor absence in the rat central nervous system. Eur J Pharmacol 1999; 377:117-25
3. 2 receptor. Eur J Pharmacol 2000; 396:141-9
4. 1 receptor knockout mice. Proc Natl Acad Sci USA 1999; 96:5780-5
5. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995; 232:54-61
6. Facci L, Dal Torso R, Romanello S, Buriani A, Skaper SD, Leon A: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 1995; 92:3376-80
7. 2: A characterization of expression and adenylate cyclase modulation within the immune system. Tox App Pharm 1997; 142:278-87
8. 2, a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 1999; 96:14228-33
9. 2 cannabinoid receptor-mediated peripheral antinociception. Pain 2001; 93:239-45
10. Richardson JD: Cannabinoids modulate pain by multiple mechanisms of action. J Pain 2000; 1:2-14
11. Richardson JD, Kilo S, Hargreaves KM: Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 1998; 75:111-9
12. 2 cannabinoid receptors are implicated in inflammatory pain. Pain 2002; 96:253-60
13. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16:109-10
14. 35S]GTPγS binding in the mouse brain Eur J Pharmacol 1997; 321:R1-3
15. 2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 1999; 126: 665-72
16. 123I-labelled AM251: A radioiodinated ligand which binds in vivo to mouse brain cannabinoid receptors. Eur J Pharmacol 1996; 307:331-8
17. Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, Makriyannis A: Binding of the non-classical cannabinoid CP55, 940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors, Life Sci 1997; 61:PL191-7
18. Hargreaves KM, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32:77-88
19. Richardson JD, Aanonsen L, Hargreaves KM: SR141716A, a cannabinoid receptor antagonist produces hyperalgesia in untreated mice. Eur J Pharmacol 2997; 319:R3-4
20. Richardson JD, Aanonsen L, Hargreaves KM: Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J Neurosci 1998; 18:451-7
21. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A: N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 1996; 300:227-36
22. Farquhar-Smith WP, Rice AS: Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. ANESTHESIOLOGY 2001; 94:507-13
23. 2): Identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 1996; 278:989-99
24. Lambert DM, DiPaolo FG, Sonveaux P, Kanyonyo M, Govaerts SJ, Hermans E, Bueb J, Delzenne NM, Tschirhart EJ: Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors. Biochem Biophys Acta 1999; 1440:266-74
25. Lambert DM, DiMarzo V: The palmitoylethanolamide and oleamide enigmas: Are these two fatty acid amides cannabimimetic? Curr Med Chem 1999; 6:757-73
26. Calignano A, La Rana G, Giuffrida A, Piomelli D: Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol 2001; 419:191-8
27. 2 receptor-mediated suppression of hypersensitivity in the rats with persistent inflammation. Society for Neuroscience Annual Meeting Abstracts 2001; 716.4
28. Price TJ, Dussor GD, Hargreaves KM, Flores CM: Expression and distribution of cannabinoid receptor subtypes in trigeminal ganglion: Colocalization with nociceptive markers. Soc Neurosci Abst 2001; A716.13
29. 1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study. Neuroscience 1999; 90:923-31
30. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J: Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994; 62:327-31
31. McMahon SB, Bennett DL, Priestly JV, Shelton DL: The biological effects of endogenous nerve factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1995; 1:774-80
32. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ: Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1994; 115:1265-75
33. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S: Cytokines, nerve growth factor and inflammatory hyperalgesia: The contribution of tumor necrosis factor alpha. Br J Pharmacol 1997; 121:417-24
34. Shu X, Mendell LM: Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin. Neurosci Lett 1999; 274:159-62
35. Shu X, Mendell LM: Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. J Neurophysiol 2001; 86:2931-8
36. Shu X, Mendell LM: Neurotrophins and hyperalgesia. Proc Natl Acad Sci USA 1999; 96:7693-6
37. Chuang H-h, Prescott ED, Kong K, Shields S, Jordt S-E, Basbaum AI, Chao MV, Julius D: Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4, 5)P2-mediated inhibition. Nature 2001; 411:957-62